CITT Issues Determination on Preliminary Injury Inquiry on Nitisinone Capsules from Sweden

On November 20, 2018, the Canadian International Trade Tribunal (CITT) determined that the dumping of Nitisinone Capsules originating or exported from Sweden has caused injury or retardation or is threatening to cause injury to the Canadian domestic industry.

The preliminary injuryinquiry followed the notification, on September 21, 2018, that the President of the Canada Border Services Agency (CBSA) had initiated investigations into the alleged injurious dumping of the above-mentioned goods. 

The subject goods are described as capsules and tablets of nitisinone with a dosage of 2 mg, 5 mg, 10 mg and 20 mg, whether or not they are packaged for retail, originating in or exported from Sweden.

The nitisinone capsules are usually classified under HS classification numbers 3004.90.00.79, 3004.90.00.90 or 3003.90.00.90. These classification numbers are provided for ease of reference only. Refer to the product definition for the authoritative details regarding the subject goods.

The statement of reasons containing additional details of the determination will be posted on CITT’s website within 15 days 

This CITT determination can be found on CITT’s website. 

Please contact your Livingston account representative should you have any questions.